Pharmaceutical Commerce - January/February 2010

Growing digitization of patient data could break the threshold to better adherence to medication therapies

The Medical Affairs function can play a vital role in today’s product launch process

Over half of all physicians are participating in social-media sites or online professional networks

How the many anticounterfeiting measures on the market today could turn into a means of connecting with patients

Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers

More and more parts of the healthcare industry are connecting

Preparing for the effects of economic recovery on a changed logistics landscape is the theme

IT developer promotes concept of 'revenue management life cycle'

Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?

While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD

Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution

In competing for pharmacy business, AmerisourceBergen, Cardinal Health and McKesson offer improved access to branded and generic products

Long in the making, could become finalized before the end of the year

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps. Next up: unused pharmaceutical returns

Capsugel will provide nano-encryption for capsules through technology license

Forbes magazine survey finds top nine drugs, all costing >$200,000 annually

Only sites certified by NABP (in the US) and CIPA (Canada) will be allowed to purchase AdWords

The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients

Drugmaker will collaborate with Web startup to develop personalized healthcare plans

USDA program started around when the FDA program did, and encountered similar problems

Patient Outcomes Research Moves Drug Development Beyond Clinical Results

Latest 10-year BLS projection sees moderate growth in US employment—except for ‘top executives’

While time- and temperature-sensitive biopharma shipping will grow dramatically in coming years, the capacity of air freight carriers is becoming constrained

Two industry communications agencies hope an online collaboration will lead to joint service offerings

Long in the making, could become finalized before the end of the year

European anticounterfeiting project tests end-to-end authentication